for other compounds, it can be up to 5 % (Green 1996)
Safety Considerations and Who Should Not Use Tirzepatide Tirzepatide is not recommended for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe kidney disease (eGFR below 15), or acute pancreatitis
Autoantibodies identified as likely driver of long COVID neurological symptoms In two other separate studies, researchers identified a potential biological mechanism behind the neurological symptoms of long Covid, finding that autoantibodies, immune system proteins that mistakenly attack the body's own tissues, may be a central cause of conditions including fatigue, pain, loss of balance, and nerve fiber damage in affected patients
Instead, opt for smaller, more frequent meals with easily digestible foods